Case 5- Diabetes Mellitus Flashcards
Causes of DM
Steroids
Pancreatitis
Pancreatic surgery
Acromegaly
Pregnancy
Metformin
Increased insulin sensitivity
Decreases hepatic gluconeogenesis
GI disturbance (if intolerable, the MR version can be trialled)
Lactic acidosis
Contraindicated in reduced eGFR (below 30)
Stop in MI (due to lactic acidosis)
Pioglitazone (Thiazolidineione)
Activate PPARgamma receptors in adipocytes to promote adipogenesis and fatty acid uptake and reduce peripheral insulin resistance
Weight gain
Fluid retention (contraindicated HF)
Bladder cancer
Liver impairment
Increase fracture risk
NB- rarely Used second line
Sulfonylurea (glicazide/glimperide)
Stimulate pancreatic beta cells to secrete insulin
Weight gain (apetite)
Hypoglycaemia
Hyponatraemia (due to SIADH)
Hepatotoxicity (cholestasis)
Increased risk of CVD when used as a mono therapy
Avoid in breast feeding and pregnancy
Overdose- hyperinsulinaemia and increased C peptide levels
DPP4 Inhibitor (sitagliptin)
Increases incretins (inhibits breakdown) which inhibit glucagon secretion
GI disturbance
Pancreatitis
GLP 1 Mimetics (liraglutide/ exenatide)
Incretin mimetic which inhibits glucagon secretion
GI disturbance
Weight loss
Pancreatitis
SGLT 2 Inhibitors (empaglifozin)
Inhibits glucose resorption in kidney (proximal convoluted tubule SGLT2 transporter), increases urinary glucose
Glucose excreted in urine- UTI
Reduced risk of CVD
Weight loss
DKA
Necrotising fasciitis if the genitalia or perineum eg. Fourniers gangrene
Increased risk of lower limb amputation
Meglitinides SE
Hypoglycaemia
Weight gain
DM blood glucose ranges
Random >11.1
OGTT >11.1
Fasting >7
HbA1c >48
NB- OGTT: don’t eat for 8-12 hours prior
HbA1C Targets
48 if on one medication
53 if one 2 or more/ hypo risk drug monotherapy/ elderly at risk of fall
If above 58- step up management
If above 80- need insulin
Symptoms of hypoglycaemia
Autonomic- tremor, pallor, anxiety, tachycardia, palpitations, hunger, nausea and vomiting
Neuroglycopenic- agitation, confusion, behavioural changes, seizures, somnolence
Hyperglycaemia symptoms
Polyuria, polydipsia, n & v, volume depletion signs, altered mental status, lethargy, coma, blurred vision, weakness
Diabetes Mellitus type 1 Sx
Typical hyperglycaemia Sx eg. Polyuria
Diabetes type 2 investigations and management
Finger prick BM
Urine- ketones and glucosuria
Bloods- HBA1c, OGTT, plasma ketones, fasting blood glucose, UE (diabetic nephropathy)
Tests for complications- fundoscopy and diabetic foot exam
DKA and HHS Investigations
Urinalysis- ketones
Bloods- FBC, ketones, UE (K will be normal but it is extra cellular so need to replace to make it intra cellular), ABG (metabolic acidosis, resp compensation), blood cultures, BM
ECG and CXR
Needs acidaemia, ketonaemia, hyperglycaemia
Replace potassium!
C peptide levels
Indicate amount of endogenous insulin being produced- very low levels indicative of type 1
NB- GAD autoantibodies serve as a marker for autoimmune diabetes in adults
HHS vs DKA
No ketones or acidaemia in HHS, and history is usually longer (glucose often more than 35 in DKA)
Diabetic foot exam
Compare one foot to another (inspection and all other steps)
Statins
QRISK greater than 10% (and no known heart disease) for type 2 diabetics or T1DM or CKD if eGFR less than 60, offer 20mg OD atorvastatin
Diabetes type 2 management
Lifestyle modifications- diet, exercise, weight loss, smoking cessation, statin and ACE-I (ARB if Afro Caribbean)
Monitoring for complications
Drug therapy- as per the 2 diagrams on passmedicine
Normal blood glucose ranges
Random <7.8
OGTT <7.8
Fasting 4-6.0
HBA1c <42
Hall marks of DKA
Acidaemia
Ketonaemia
Hyperglycaemia
Hallmarks of HHS
Hyperglycaemia
Hyper osmolarity
Volume depletion
NO KETOSIS
Diagnose DKA
pH <7.3 (or bicarbonate <15)
Ketones >3 or more than 2+ on dipstick
BM >11 or known diabetic
Diagnose HHS
Glucose >11
Osmolarity >320
Absence of significant ketosis